| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 07/31/2023 | 8.49% | Keybanc | $53 → $51 | Maintains | Overweight |
| 07/28/2023 | -6.4% | Wells Fargo | $46 → $44 | Maintains | Equal-Weight |
| 07/12/2023 | 19.12% | Stifel | $54 → $56 | Maintains | Buy |
| 05/30/2023 | -4.28% | Morgan Stanley | → $45 | Assumes | → Equal-Weight |
| 05/01/2023 | 23.38% | Barclays | $54 → $58 | Maintains | Overweight |
| 04/28/2023 | -0.02% | Citigroup | $44 → $47 | Maintains | Neutral |
| 04/28/2023 | 6.36% | Deutsche Bank | $40 → $50 | Maintains | Hold |
| 04/28/2023 | 14.87% | Stifel | $45 → $54 | Maintains | Buy |
| 04/28/2023 | 2.11% | Morgan Stanley | $44 → $48 | Maintains | Equal-Weight |
| 04/28/2023 | 12.74% | Keybanc | $52 → $53 | Maintains | Overweight |
| 04/04/2023 | 2.11% | Evercore ISI Group | $50 → $48 | Maintains | Outperform |
| 03/29/2023 | -8.53% | UBS | → $43 | Initiates Coverage On | → Neutral |
| 02/13/2023 | -6.4% | Citigroup | $58 → $44 | Maintains | Neutral |
| 02/13/2023 | 14.87% | Barclays | $63 → $54 | Maintains | Overweight |
| 02/10/2023 | -8.53% | Wells Fargo | $52 → $43 | Maintains | Equal-Weight |
| 02/10/2023 | -4.28% | Cowen & Co. | $70 → $45 | Maintains | Outperform |
| 02/10/2023 | -6.4% | Morgan Stanley | $55 → $44 | Maintains | Equal-Weight |
| 02/10/2023 | 10.61% | Keybanc | $60 → $52 | Maintains | Overweight |
| 02/06/2023 | 27.63% | Keybanc | $73 → $60 | Maintains | Overweight |
| 01/09/2023 | 10.61% | Wells Fargo | $57 → $52 | Maintains | Equal-Weight |
| 01/06/2023 | 17% | Morgan Stanley | → $55 | Downgrades | Overweight → Equal-Weight |
| 01/05/2023 | — | Raymond James | Downgrades | Outperform → Market Perform | |
| 01/03/2023 | 17% | B of A Securities | → $55 | Downgrades | Buy → Neutral |
| 12/19/2022 | 17% | JP Morgan | $68 → $55 | Downgrades | Overweight → Neutral |
| 12/15/2022 | 21.25% | Wells Fargo | $59 → $57 | Maintains | Equal-Weight |
| 12/15/2022 | 8.49% | Deutsche Bank | $69 → $51 | Downgrades | Buy → Hold |
| 12/12/2022 | 23.38% | Citigroup | $64 → $58 | Downgrades | Buy → Neutral |
| 11/03/2022 | 12.74% | Goldman Sachs | $60 → $53 | Maintains | Sell |
| 10/28/2022 | 29.76% | Raymond James | $66 → $61 | Maintains | Outperform |
| 10/28/2022 | 25.51% | Wells Fargo | $63 → $59 | Maintains | Equal-Weight |
| 10/28/2022 | 55.29% | Keybanc | $77 → $73 | Maintains | Overweight |
| 10/18/2022 | 36.14% | Barclays | → $64 | Initiates Coverage On | → Overweight |
| 10/12/2022 | 31.89% | Jefferies | → $62 | Initiates Coverage On | → Hold |
| 10/11/2022 | 48.9% | Morgan Stanley | $72 → $70 | Maintains | Overweight |
| 08/03/2022 | 27.63% | Goldman Sachs | $70 → $60 | Maintains | Sell |
| 07/29/2022 | 40.4% | Raymond James | $85 → $66 | Maintains | Outperform |
| 07/29/2022 | 53.16% | Morgan Stanley | $86 → $72 | Maintains | Overweight |
| 07/18/2022 | 59.54% | Stifel | $85 → $75 | Maintains | Buy |
| 07/15/2022 | 82.94% | Morgan Stanley | $95 → $86 | Maintains | Overweight |
| 06/24/2022 | 65.92% | JP Morgan | $90 → $78 | Maintains | Overweight |
| 06/24/2022 | 51.03% | Wells Fargo | → $71 | Downgrades | Overweight → Equal-Weight |
| 05/23/2022 | 102.08% | Morgan Stanley | $100 → $95 | Maintains | Overweight |
| 05/17/2022 | 80.81% | Citigroup | $98 → $85 | Maintains | Buy |
| 04/29/2022 | 80.81% | Raymond James | $96 → $85 | Maintains | Outperform |
| 04/29/2022 | 112.72% | Morgan Stanley | $105 → $100 | Maintains | Overweight |
| 04/29/2022 | 91.45% | Wells Fargo | $93 → $90 | Maintains | Overweight |
| 04/29/2022 | 85.07% | Keybanc | $95 → $87 | Maintains | Overweight |
| 04/04/2022 | 63.79% | Goldman Sachs | $88 → $77 | Downgrades | Neutral → Sell |
| 02/18/2022 | 123.36% | Morgan Stanley | $110 → $105 | Maintains | Overweight |
| 02/18/2022 | 104.21% | Raymond James | $99 → $96 | Maintains | Outperform |
| 02/18/2022 | 102.08% | Keybanc | $98 → $95 | Maintains | Overweight |
| 01/07/2022 | 133.99% | Morgan Stanley | $86 → $110 | Upgrades | Equal-Weight → Overweight |
| 01/04/2022 | 110.59% | Raymond James | $93 → $99 | Maintains | Outperform |
| 01/04/2022 | 108.47% | Keybanc | $92 → $98 | Maintains | Overweight |
| 10/29/2021 | 82.94% | Morgan Stanley | $90 → $86 | Maintains | Equal-Weight |
| 09/13/2021 | 108.47% | Cowen & Co. | → $98 | Upgrades | Market Perform → Outperform |
| 09/03/2021 | 112.72% | Barclays | $93 → $100 | Upgrades | Equal-Weight → Overweight |
| 08/03/2021 | 70.18% | Goldman Sachs | $93 → $80 | Maintains | Neutral |
| 08/02/2021 | 95.7% | Keybanc | $94 → $92 | Maintains | Overweight |
| 05/25/2021 | 97.83% | Barclays | → $93 | Initiates Coverage On | → Equal-Weight |
| 04/30/2021 | 108.47% | Citigroup | $94 → $98 | Maintains | Buy |
| 02/05/2021 | 102.08% | Credit Suisse | $99 → $95 | Maintains | Outperform |
| 02/05/2021 | 80.81% | Raymond James | $88 → $85 | Maintains | Outperform |
| 01/29/2021 | 70.18% | Piper Sandler | $100 → $80 | Downgrades | Overweight → Neutral |
| 12/15/2020 | 91.45% | Morgan Stanley | $84 → $90 | Maintains | Equal-Weight |
| 11/02/2020 | 87.19% | Stifel | $90 → $88 | Maintains | Buy |
| 10/30/2020 | 78.69% | Morgan Stanley | $90 → $84 | Maintains | Equal-Weight |
| 10/30/2020 | 99.96% | Keybanc | $98 → $94 | Maintains | Overweight |
| 10/12/2020 | 87.19% | Raymond James | $95 → $88 | Maintains | Outperform |
| 10/09/2020 | 104.21% | UBS | $98 → $96 | Maintains | Buy |
| 10/01/2020 | 99.96% | Citigroup | → $94 | Upgrades | Neutral → Buy |
| 09/04/2020 | — | Argus Research | Downgrades | Buy → Hold | |
| 07/31/2020 | 102.08% | Raymond James | $97 → $95 | Maintains | Outperform |
| 07/31/2020 | 91.45% | Morgan Stanley | $95 → $90 | Maintains | Equal-Weight |
| 06/24/2020 | 112.72% | Oppenheimer | → $100 | Initiates Coverage On | → Outperform |
| 05/01/2020 | 119.1% | UBS | $95 → $103 | Maintains | Buy |
| 05/01/2020 | 123.36% | SVB Leerink | $96 → $105 | Maintains | Outperform |
| 05/01/2020 | 110.59% | Credit Suisse | $97 → $99 | Maintains | Outperform |
| 05/01/2020 | 108.47% | Keybanc | $92 → $98 | Maintains | Overweight |
| 04/28/2020 | 104.21% | JP Morgan | $94 → $96 | Maintains | Overweight |
| 04/13/2020 | 106.34% | Raymond James | $90 → $97 | Maintains | Outperform |
| 03/27/2020 | 102.08% | Morgan Stanley | $88 → $95 | Maintains | Equal-Weight |
| 03/19/2020 | 102.08% | Stifel | $87 → $95 | Upgrades | Hold → Buy |
| 03/18/2020 | 89.32% | Citigroup | $94 → $89 | Maintains | Neutral |
| 03/18/2020 | 110.59% | Deutsche Bank | $109 → $99 | Maintains | Buy |
| 03/18/2020 | 104.21% | Credit Suisse | $98 → $96 | Maintains | Outperform |
| 03/18/2020 | 91.45% | Raymond James | $95 → $90 | Maintains | Outperform |
| 03/18/2020 | 95.7% | Keybanc | → $92 | Upgrades | Sector Weight → Overweight |
| 03/06/2020 | 108.47% | Credit Suisse | $95 → $98 | Maintains | Outperform |
| 03/05/2020 | 99.96% | Citigroup | → $94 | Initiates Coverage On | → Neutral |
| 02/14/2020 | 116.98% | Wells Fargo | $100 → $102 | Maintains | Overweight |
| 02/13/2020 | 121.23% | Goldman Sachs | → $104 | Initiates Coverage On | → Buy |
| 02/06/2020 | 97.83% | CFRA | $87 → $93 | Maintains | Hold |
| 01/16/2020 | 112.72% | Wells Fargo | $95 → $100 | Maintains | Overweight |
| 01/02/2020 | 99.96% | Evercore ISI Group | → $94 | Upgrades | In-Line → Outperform |
| 12/20/2019 | 99.96% | JP Morgan | $89 → $94 | Maintains | Overweight |
| 12/17/2019 | 87.19% | Morgan Stanley | $90 → $88 | Downgrades | Overweight → Equal-Weight |
| 10/28/2019 | 102.08% | UBS | $98 → $95 | Maintains | Buy |
| 07/26/2019 | 102.08% | Credit Suisse | $84 → $95 | Maintains | Outperform |
| 06/26/2019 | 93.58% | Wells Fargo | $89 → $91 | Maintains | Outperform |
| 06/26/2019 | — | Keybanc | Initiates Coverage On | → Sector Weight | |
| 04/15/2019 | 59.54% | Barclays | $72 → $75 | Maintains | Equal-Weight |
| 04/08/2019 | — | Evercore ISI Group | Downgrades | Outperform → In-Line | |
| 04/03/2019 | 89.32% | Wells Fargo | $80 → $89 | Maintains | Outperform |
| 03/05/2019 | 76.56% | Morgan Stanley | $80 → $83 | Maintains | Overweight |
| 02/01/2019 | 53.16% | Barclays | $67 → $72 | Upgrades | Underweight → Equal-Weight |
| 01/02/2019 | 61.67% | Citigroup | $69 → $76 | Upgrades | Neutral → Buy |
| 01/02/2019 | 63.79% | Morgan Stanley | $66 → $77 | Upgrades | Equal-Weight → Overweight |
| 12/18/2018 | 63.79% | Credit Suisse | → $77 | Initiates Coverage On | → Outperform |
| 12/04/2018 | 61.67% | Wells Fargo | $72 → $76 | Maintains | Outperform |
| 11/28/2018 | 70.18% | UBS | → $80 | Initiates Coverage On | → Buy |
| 11/13/2018 | 46.78% | Citigroup | $76 → $69 | Maintains | Neutral |
| 11/08/2018 | 48.9% | RBC Capital | $76 → $70 | Maintains | Sector Perform |
| 11/05/2018 | 40.4% | Morgan Stanley | $75 → $66 | Maintains | Underweight |
| 11/02/2018 | 48.9% | Argus Research | → $70 | Upgrades | Hold → Buy |
| 11/01/2018 | 53.16% | Wells Fargo | $82 → $72 | Maintains | Outperform |
| 11/01/2018 | 61.67% | BMO Capital | $86 → $76 | Maintains | Outperform |
| 11/01/2018 | 63.79% | Leerink Swann | $90 → $77 | Maintains | Outperform |
| 11/01/2018 | 57.41% | Raymond James | $80 → $74 | Maintains | Outperform |
| 10/16/2018 | 55.29% | Barclays | → $73 | Initiates Coverage On | → Underweight |
| 10/11/2018 | 59.54% | Morgan Stanley | $68 → $75 | Maintains | Underweight |
| 07/31/2018 | 61.67% | Citigroup | $74 → $76 | Maintains | Neutral |
What is the target price for Baxter Intl (BAX)?
The latest price target for Baxter Intl (NYSE: BAX) was reported by Keybanc on July 31, 2023. The analyst firm set a price target for $51.00 expecting BAX to rise to within 12 months (a possible 8.49% upside). 35 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Baxter Intl (BAX)?
The latest analyst rating for Baxter Intl (NYSE: BAX) was provided by Keybanc, and Baxter Intl maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Baxter Intl (BAX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Baxter Intl, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Baxter Intl was filed on July 31, 2023 so you should expect the next rating to be made available sometime around July 31, 2024.
Is the Analyst Rating Baxter Intl (BAX) correct?
While ratings are subjective and will change, the latest Baxter Intl (BAX) rating was a maintained with a price target of $53.00 to $51.00. The current price Baxter Intl (BAX) is trading at is $47.01, which is out of the analyst's predicted range.